In episode 493, Mike and James review all the Long COVID data. We talk about how many people get it, what the symptoms are and how long it can persist – and it can be a long time. COVID long-term is different than what we see with the regular flu. Show… Read More
In episode 492, Mike and James delve into a couple of potentially practice-changing results. The first trial looked at the effect of different shoes for knee osteoarthritis. You might be surprised by the results. The second trial is the first ever look at a salt substitute and what it does,… Read More
In episode 491, Mike and James invite Mike Kolber to talk about Pink Ladies and White Knights. In medical terms we are referring to whether or not it makes sense to add lidocaine and antispasmodics to antacids in patients who present to an emergency room with dyspepsia. Please ignore the parts… Read More
In episode 490, Mike and James invite Tony and Mike to go over the best available evidence for ivermectin. Overall the evidence shows that ivermectin does not improve clinically important outcomes. Unfortunately, much of the evidence for ivermectin is unpublished and some has even been retracted. Show Notes Tools for Practice… Read More
In episode 489, Mike and James invite Adrienne to go over the evidence for weight loss with semaglutide. We find the evidence shows that weight loss is on average roughly 10 kg over the effect of placebo, however this comes at the expense and inconvenience (injection) of the medication and… Read More
